Xigduo XR 5/1000 24HR Extended Release Oral Tablet

RxCUI: 1593833
RxNorm name: Xigduo XR 5/1000 24HR Extended Release Oral Tablet
Display name: Xigduo XR 5/1000 24HR Extended Release Oral Tablet
Full name: Xigduo XR 5/1000 24HR Extended Release Oral Tablet
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:15

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
XIGDUO XR	DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE	AstraZeneca Pharmaceuticals LP	ac8a0f7b-9f69-4495-abbc-3a47cd75a859	2024-12-20	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1593833

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
ac8a0f7b-9f69-4495-abbc-3a47cd75a859	Xigduo XR 5/1000 24HR Extended Release Oral Tablet	PSN	38	These highlights do not include all the information needed to use XIGDUO XR safely and effectively. See full prescribing information for XIGDUO XR. XIGDUO ® XR (dapagliflozin and metformin hydrochloride extended-release) tablets, for oral use Initial U.S. Approval: 2014	20241220
ac8a0f7b-9f69-4495-abbc-3a47cd75a859	Xigduo XR 5/1000 24HR Extended Release Oral Tablet	SY	38	These highlights do not include all the information needed to use XIGDUO XR safely and effectively. See full prescribing information for XIGDUO XR. XIGDUO ® XR (dapagliflozin and metformin hydrochloride extended-release) tablets, for oral use Initial U.S. Approval: 2014	20241220
ac8a0f7b-9f69-4495-abbc-3a47cd75a859	24 HR dapagliflozin 5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet [Xigduo]	SBD	38	These highlights do not include all the information needed to use XIGDUO XR safely and effectively. See full prescribing information for XIGDUO XR. XIGDUO ® XR (dapagliflozin and metformin hydrochloride extended-release) tablets, for oral use Initial U.S. Approval: 2014	20241220